Pfizer sues Metsera, Novo Nordisk
Digest more
Drugmaker Pfizer on Friday sued obesity-drug developer Metsera and Novo Nordisk, seeking to block Metsera from terminating ...
For Novo, it marks the boldest move yet for recently appointed CEO Maziar Mike Doustdar. In response to a slowdown in sales growth for its blockbuster obesity drug Wegovy, Doustdar has already ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback